Etomidate induces cytotoxic effects and gene expression in a murine leukemia macrophage cell line (RAW264.7)

Rick Sai-Chuen Wu1, King-Chuen Wu, Jai-Sing Yang

  • 1Department of Anesthesiology, China Medical University Hospital, and Department of Pharmacology, School of Pharmacy, China Medical University, No 91, Hsueh-Shih Road, Taichung 404, Taiwan, ROC.

Anticancer Research
|July 9, 2011
PubMed

Insights

Etomidate, a common anesthetic, was found to induce cell death and apoptosis in murine leukemia cells. This study investigated etomidate

Area of Science:

  • Cell Biology
  • Pharmacology
  • Toxicology

Background:

  • Etomidate is widely used by emergency physicians for intubation and procedural sedation.
  • Understanding the cellular mechanisms of etomidate is crucial for its safe application.

Purpose of the Study:

  • To investigate the in vitro cytotoxicity of etomidate on murine leukemia RAW264.7 cells.
  • To examine etomidate's role in inducing apoptosis and altering protein and gene expression related to cell death.

Main Methods:

  • RAW264.7 cells were treated with etomidate.
  • Cytotoxicity and apoptosis were assessed using phase-contrast microscopy and flow cytometry.
  • Protein expression was analyzed by Western blotting, and gene expression by DNA microarray.

Main Results:

  • Etomidate significantly increased apoptotic morphological changes and decreased cell viability in RAW264.7 cells.
  • Western blotting revealed increased levels of pro-apoptotic proteins (cytochrome c, AIF, Endo G, caspase-9, caspase-3, Bax) and decreased Bcl-xl.
  • DNA microarray identified 17 upregulated and 15 downregulated genes following etomidate treatment.

Conclusions:

  • Etomidate induces significant cytotoxic and apoptotic effects in murine leukemia RAW264.7 cells in vitro.
  • The drug modulates key proteins and genes involved in the apoptotic pathway.

Related Concept Videos